Skip to main content
logo
AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
3.480
+0.030 (0.87%)
Jan 2, 2026, 11:54 AM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Jun '21 Jun '20 2015 - 2019
Commercial
64.02M
Log In
Log In
Log In
Log In
Upgrade
Commercial Growth
28.62%
Log In
Log In
Log In
Log In
Upgrade
Biomedical Advanced Research and Development Authority Revenue for Right of First Access
195.00K
Log In
Log In
Log In
Log In
Upgrade
Biomedical Advanced Research and Development Authority Revenue for Right of First Access Growth
-41.79%
Log In
Log In
Log In
Log In
Upgrade
Deferred Commercial
33.00K
Log In
Log In
Log In
Log In
Upgrade
Deferred Commercial Growth
0%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Jun '21 Jun '20 2015 - 2019
United States
62.16M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
34.08%
Log In
Log In
Log In
Log In
Upgrade
Japan
1.43M
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
-57.54%
Log In
Log In
Log In
Log In
Upgrade
Australia
312.00K
Log In
Log In
Log In
Log In
Upgrade
Australia Growth
40.54%
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
196.00K
Log In
Log In
Log In
Log In
Upgrade
United Kingdom Growth
39.01%
Log In
Log In
Log In
Log In
Upgrade
European Union
155.00K
Log In
Log In
Log In
Log In
Upgrade
European Union Growth
203.92%
Log In
Log In
Log In
Log In
Upgrade